Skip to main content
Clinical Trials/NCT03828786
NCT03828786CompletedNot Applicable

The Impact of Uterine Scratching Prior to Intra-Uterine Insemination in Unexplained Infertility, a Randomized Controlled Trial

Clinique Ovo2 sites in 1 country394 target enrollmentStarted: July 15, 2018Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
394
Locations
2
Primary Endpoint
Efficacy - Pregnancy Rate measured during the first trimester ultrasound.

Study Overview

Brief Summary

This study will evaluate the potential benefits of uterine injury during the follicular phase of an intra-uterine insemination cycle on the rate of ongoing pregnancy during the first trimester ultrasound.

Detailed Description

Infertility is defined as the absence of conception after a year of unprotected intercourse. In 10 to 30 % of patients, the cause of the infertility is unknown. An emerging practice in unexplained infertility has been to cause a uterine trauma prior to treatment. This is done by doing a small endometrial scratch with a pipelle. This intervention has been study in IVF and has been shown beneficial. Theoretically, the uterine scratching could increase the immune response and the vascularization of the endometrium which could help in embryo implantation. However, there is very few data concerning scratching in intrauterine insemination. The studies are mostly small studies and the results are often contradictory. In this randomized controlled trial, the investigators will evaluate the effect of uterine scratching during the follicular phase of an insemination cycle on the pregnancy rate of a large cohort of unexplained infertile couples.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 41 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Unexplained infertility for over 12 months if under 35 years old or over 6 months if 35 years old and above.
  • At least one permeable tube on hysterosonography or hysterosalpingography within the last 2 years or vaginal delivery in the last 3 years.
  • Antral follicular count over
  • Normal or mild male factor.
  • Normal uterine cavity.
  • An IUI prescription.

Exclusion Criteria

  • Polycystic ovary syndrome with irregular menstrual cycles over 45 days
  • Severe endometriosis
  • IUI with Donor sperm
  • Patient with invasive intra-uterine procedure in the last 3 months.
  • Contraindication to endometrial biopsy.

Outcomes

Primary Outcomes

Efficacy - Pregnancy Rate measured during the first trimester ultrasound.

Time Frame: 13 weeks

Ongoing pregnancy during the first trimester ultrasound after an intrauterine insemination (IUI) cycle.

Secondary Outcomes

  • Efficacy - Secondary pregnancy rate.(6 months)
  • Safety - Complications(6 months for all 3 intrauterine insemination)
  • Safety - Side effects(6 months for all 3 intrauterine insemination)

Investigators

Sponsor
Clinique Ovo
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials